Pulmonology Medical News about Bordetella pertussis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Improved selective isolation of Bordetella pertussis by modified cyclodextrin solid medium
Journal of Clinical Microbiology, 10/23/09

Ohtsuka M et al. – The authors have developed a modified cyclodextrin solid medium using the selective antibiotic, cefdinir. MCS medium exhibited higher sensitivity and greater inhibition of nasopharyngeal flora than Bordet–Gengou agar or cyclodextrin solid medium.

<< Previous
Cystic fibrosis neutrophils have normal intrinsic reactive oxygen...

Next >>
An Outbreak of Acute Respiratory Disease Caused by Mycoplasma...

Bordetella pertussis and Pertussis Vaccines
Clinical Infectious Diseases, 10/28/09 Relevance Score: 67%

Keeping Vulnerable Children Safe from Pertussis: Preventing Nosocomial Pertussis Transmission in the Neonatal Intensive Care Unit
Infection Control and Hospital Epidemiology, 10/13/09 Relevance Score: 45%

Pertussis antibodies in postpartum women and their newborns
Journal of Perinatology, 10/13/09 Relevance Score: 43%

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09 Relevance Score: 40%

Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: Systematic review of randomized controlled trials and quasi-randomized controlled trials
Clinical Therapeutics, 10/16/09 Relevance Score: 40%